---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-25-023014"
form_type: "8-K"
ticker: "AXTI"
cik: "0001051627"
company_name: "AXT INC"
filed_at: "2025-07-18T23:59:59+00:00"
generated_at: "2026-05-18T05:32:35.967365+00:00"
event_type: "regulatory"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# AXT reports board director death; Audit Committee now non-compliant with Nasdaq rule

## Summary
- Christine Russell, independent director and Audit Committee Chair, passed away on July 11, 2025.
- Audit Committee reduced to two independent directors, violating Nasdaq Listing Rule 5605(c)(2)(A).
- Company has cure period until earlier of next annual meeting or July 11, 2026 to regain compliance.
- Board will begin search for a new independent director qualified for Audit Committee.
- No other listing issues; common stock continues trading on Nasdaq under symbol AXTI.

## SEC filing metadata
- accession: 0001437749-25-023014
- form_type: 8-K
- ticker: AXTI
- cik: 0001051627
- company_name: AXT INC
- filed_at: 2025-07-18T23:59:59+00:00
- event_type: regulatory
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 3.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1051627/000143774925023014/0001437749-25-023014-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1051627/000143774925023014/axti20250715_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-25-023014
- JSON: https://secwatch.observer/filing/0001437749-25-023014.json
- Plain text: https://secwatch.observer/filing/0001437749-25-023014.txt

## Source-grounded claims
- claim_id: bc3d82082fa61c92fa4ae1b15ada4b838672603a
  claim: AXT INC received a nasdaq noncompliance notice notice regarding audit committee (rules 5605(c)(2)(A), 5605(c)(4)(B)).
  evidence_excerpt: July 14, 2025, the Company notified The Nasdaq Stock Market LLC (“Nasdaq”) that due to Ms. Russell's death, the Company’s Audit Committee has been reduced to two independent directors, and the Company is not compliant with Nasdaq Lising Rule 5605(c)(2)(A), which requires the Audit Committee to be comprised of a minimum of three independent directors. Pursuant to Nasdaq Listing Rule 5605(c)(4)(B), the Company has a cure period to regain compliance until the earlier of the Company’s next annual meeting of stockholders or July 11, 2026. The Company intends to regain compliance as soon as possible
  evidence_url: https://www.sec.gov/Archives/edgar/data/1051627/000143774925023014/0001437749-25-023014-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.